Ubiquitinylation of α-Synuclein by Carboxyl Terminus Hsp70-Interacting Protein (CHIP) Is Regulated by Bcl-2-Associated Athanogene 5 (BAG5)
2011

How CHIP and BAG5 Interact to Regulate Alpha-Synuclein in Parkinson's Disease

publication 10 minutes Evidence: moderate

Author Information

Author(s): Kalia Lorraine V., Kalia Suneil K., Chau Hien, Lozano Andres M., Hyman Bradley T., McLean Pamela J.

Primary Institution: Massachusetts General Hospital, Harvard Medical School

Hypothesis

Does BAG5 inhibit the ubiquitinylation of alpha-synuclein by CHIP?

Conclusion

The study identifies CHIP as an E3 ubiquitin ligase for alpha-synuclein and shows that BAG5 inhibits this process, potentially affecting alpha-synuclein oligomerization.

Supporting Evidence

  • CHIP was shown to ubiquitinylate alpha-synuclein, reducing its oligomerization.
  • BAG5 was found to inhibit the ubiquitinylation of alpha-synuclein by CHIP.
  • Co-immunoprecipitation experiments demonstrated the interaction between CHIP, BAG5, and alpha-synuclein.
  • Luciferase-based assays indicated that BAG5 mitigates the ability of CHIP to reduce alpha-synuclein oligomers.

Takeaway

This study shows that a protein called CHIP helps tag another protein, alpha-synuclein, for recycling in cells, but another protein, BAG5, can stop this from happening, which might be important in diseases like Parkinson's.

Methodology

The study used a combination of in vitro assays, co-immunoprecipitation, and luciferase-based protein-fragment complementation assays to investigate the interactions and effects of CHIP and BAG5 on alpha-synuclein.

Limitations

The study primarily focuses on in vitro models, which may not fully replicate in vivo conditions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0014695

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication